Emergex raises more than USD 11 million in a Series A Round to progress its pipeline of Set-Point Vaccines to prevent some of the world’s most immediate and virulent diseases such as Zika, Dengue Fever, Ebola and pandemic Flu.
A recent Report by Galen Growth shows Asia's HealthTech Activity in 2019 remained strong at USD 5 billion across 340 deals. Funding records were broken in Southeast Asia and India while China hit historical lows.
UCARE.AI, a Singapore-based health start-up, announces its AI-Powered Pre-Admission Cost of Hospitalisation Estimation APACHE system; enabling major hospitals in Singapore to offer fixed prices for certain medical procedures.
The biopharmaceuticals market is increasing due to a growing aging population globally; The market was valued at USD160.4 million in 2014, and it is expected to grow with a CAGR of 9.6% during the period 2015 - 2020.
Child Health Imprints Raises USD 2.4 Million in Pre-Series A Funding; it develops neonatal ICU solutions to provide real-time data and analytics, assisting clinicians in monitoring and treating at-risk newborn babies.
Employers in the US are getting savvy with opting for value-based healthcare for employees rather than the conventional volume-based delivery system; the value-based model is proving to drive significant cost efficiencies and improve the overall quality of healthcare services' delivery.
The global geriatric market is expected to reach over a USD1 trillion by 2022, a growth of 7 percent, primarily driven by regions like North America, China, Japan, India, Brazil, Spain, France and South Korea.
Ageing population and prosperity is linked to the largest healthcare boom in Australia. The opportunities this presents for everyday Australians and private healthcare practitioners may lie in smart technology.